NCT01268423

Brief Summary

The aim of the study is to determine if performing an early tracheostomy (within the first 4 days of endotracheal intubation) in critically ill patients on mechanical ventilation, reduces the incidence of swallowing dysfunction.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Jan 2011

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 29, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 30, 2010

Completed
2 days until next milestone

Study Start

First participant enrolled

January 1, 2011

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2012

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2012

Completed
Last Updated

January 5, 2011

Status Verified

December 1, 2010

Enrollment Period

1.2 years

First QC Date

December 29, 2010

Last Update Submit

January 4, 2011

Conditions

Keywords

Percutaneous tracheostomySwallowing dysfunctionMechanical ventilationIntensive Care

Outcome Measures

Primary Outcomes (1)

  • Incidence of swallowing dysfunction

    The diagnosis of swallowing dysfunction will be performed by fiberoptic endoscopic evaluation of swallowing (FEES) 3 to 5 days after weaning of mechanical ventilation.

    3 to 5 days after weaning of mechanical ventilation

Secondary Outcomes (8)

  • Ventilator-free days

    28 days

  • Incidence of ventilator-associated pneumonia

    28 days

  • Delirium-free and coma-free days

    28 days

  • Daily dose of sedatives

    28 days

  • ICU-free days

    28 days

  • +3 more secondary outcomes

Study Arms (2)

Early percutaneous tracheostomy

EXPERIMENTAL
Procedure: Percutaneous tracheostomy

Prolonged translaryngeal intubation

ACTIVE COMPARATOR
Procedure: Prolonged translaryngeal intubation

Interventions

Percutaneous tracheostomy within the first 4 days of mechanical ventilation.

Also known as: Percutaneous dilatational tracheostomy
Early percutaneous tracheostomy

Prolonged endotracheal intubation, and reevaluation at day 10 to establish the requirement of percutaneous tracheostomy. If clinical condition determines that the patient needs a percutaneous tracheostomy, this will be performed between days 11 and 14.

Also known as: Prolonged endotracheal intubation
Prolonged translaryngeal intubation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Written informed consent has been obtained for the procedure
  • Patients whose need of mechanical ventilation is estimated in ≥ 7 days and require a percutaneous tracheostomy

You may not qualify if:

  • Patients younger than 18 years old
  • Patients with neurologic pathology
  • Patients with dysphagia history
  • Patients whose MV duration is estimated in \< 7 days
  • Patients with airway obstruction requiring an emergency tracheostomy
  • Patients already having a tracheostomy in situ
  • Pregnancy
  • Patients who have already been enrolled on another trial
  • Patients with absolute contraindication to perform a percutaneous tracheostomy
  • Patients with high risk of dying, life expectancy of \< 48 hours
  • Patients in whom limitation of therapy has been decided
  • Family rejection to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Clínico Universidad de Chile

Santiago, Santiago Metropolitan, Chile

RECRUITING

MeSH Terms

Conditions

Deglutition Disorders

Condition Hierarchy (Ancestors)

Esophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic Diseases

Study Officials

  • Carlos M Romero, MD

    University of Chile

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 29, 2010

First Posted

December 30, 2010

Study Start

January 1, 2011

Primary Completion

April 1, 2012

Study Completion

June 1, 2012

Last Updated

January 5, 2011

Record last verified: 2010-12

Locations